IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $462 | +35.1% | 29,125 | +60.6% | 0.04% | +29.6% |
| Q2 2023 | $342 | +14.8% | 18,133 | -76.7% | 0.03% | +22.7% |
| Q1 2023 | $298 | -16.3% | 77,663 | +8.3% | 0.02% | -26.7% |
| Q4 2022 | $356 | -99.9% | 71,705 | +10.1% | 0.03% | +3.4% |
| Q3 2022 | $311,000 | -19.4% | 65,128 | -24.1% | 0.03% | -17.1% |
| Q2 2022 | $386,000 | +89.2% | 85,764 | +100.4% | 0.04% | +400.0% |
| Q1 2022 | $204,000 | +104.0% | 42,786 | +218.2% | 0.01% | +75.0% |
| Q4 2021 | $100,000 | +5.3% | 13,448 | -19.9% | 0.00% | 0.0% |
| Q3 2021 | $95,000 | -25.2% | 16,798 | +7.4% | 0.00% | -60.0% |
| Q1 2021 | $127,000 | – | 15,645 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |